Literature DB >> 7992847

Patterns of p53 mutations in squamous cell carcinoma of the lung. Acquisition at a relatively early age.

J Zheng1, Q Shu, Z H Li, J I Tsao, L M Weiss, D Shibata.   

Abstract

Squamous cell carcinoma (SQCC) of the lung is thought to arise after the accumulation of multiple mutations, including p53. To better characterize when p53 mutations are acquired, 37 SQCC of the lung were examined by polymerase chain reaction and single-strand conformation polymorphism analysis. Somatic p53 mutations were detected in nine tumors (24.3%). There were no significant differences in the stage, sex, or race between patients with or without p53 mutations. However, the patients with SQCC and p53 mutations were significantly (P = 0.0006) younger (mean age, 54.3 years) compared with patients without p53 mutations (mean age, 65). The topographical tissue distributions of the p53 mutations were examined by selective ultraviolet radiation fractionation. In all nine cases, the specific p53 mutant alleles were homogeneously present throughout the primary tumors, in all three examples with in situ carcinoma, and in all four cases with metastases. In one case, squamous metaplasia contiguous with the primary tumor also contained the same p53 mutation. Normal or hyperplastic and metaplastic or dysplastic epithelium not contiguous with the primary tumors lacked the specific p53 mutations. These findings suggest that p53 mutations are commonly acquired at a relatively early age, before the bulk of clonal expansion, and usually persist throughout the progression of SQCC of the lung.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7992847      PMCID: PMC1887485     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  29 in total

1.  Deletions of 17p and p53 mutations in preneoplastic lesions of the lung.

Authors:  G Sozzi; M Miozzo; R Donghi; S Pilotti; C T Cariani; U Pastorino; G Della Porta; M A Pierotti
Journal:  Cancer Res       Date:  1992-11-01       Impact factor: 12.701

2.  Molecular analysis of the short arm of chromosome 3 in small-cell and non-small-cell carcinoma of the lung.

Authors:  H Brauch; B Johnson; J Hovis; T Yano; A Gazdar; O S Pettengill; S Graziano; G D Sorenson; B J Poiesz; J Minna
Journal:  N Engl J Med       Date:  1987-10-29       Impact factor: 91.245

3.  Development of carcinoma of the lung as reflected in exfoliated cells.

Authors:  G Saccomanno; V E Archer; O Auerbach; R P Saunders; L M Brennan
Journal:  Cancer       Date:  1974-01       Impact factor: 6.860

4.  Mutational activation of the K-ras oncogene. A possible pathogenetic factor in adenocarcinoma of the lung.

Authors:  S Rodenhuis; M L van de Wetering; W J Mooi; S G Evers; N van Zandwijk; J L Bos
Journal:  N Engl J Med       Date:  1987-10-08       Impact factor: 91.245

5.  Relationships of morphology to clinical presentation in ten cases of early squamous cell carcinoma of the lung.

Authors:  D Carter; B R Marsh; R Baker; Y S Erozan; J K Frost
Journal:  Cancer       Date:  1976-03       Impact factor: 6.860

6.  The clonal evolution of tumor cell populations.

Authors:  P C Nowell
Journal:  Science       Date:  1976-10-01       Impact factor: 47.728

7.  p53 and chromosome 3 abnormalities, characteristic of malignant lung tumours, are detectable in preinvasive lesions of the bronchus.

Authors:  V Sundaresan; P Ganly; P Hasleton; R Rudd; G Sinha; N M Bleehen; P Rabbitts
Journal:  Oncogene       Date:  1992-10       Impact factor: 9.867

8.  p53 mutations in primary human lung tumors and their metastases.

Authors:  M B Reichel; H Ohgaki; I Petersen; P Kleihues
Journal:  Mol Carcinog       Date:  1994-02       Impact factor: 4.784

9.  Aberrations of the p53 tumor suppressor gene in human non-small cell carcinomas of the lung.

Authors:  Y Kishimoto; Y Murakami; M Shiraishi; K Hayashi; T Sekiya
Journal:  Cancer Res       Date:  1992-09-01       Impact factor: 12.701

10.  Smoking and lung cancer with special regard to type of smoking and type of cancer. A case-control study in north Sweden.

Authors:  L A Damber; L G Larsson
Journal:  Br J Cancer       Date:  1986-05       Impact factor: 7.640

View more
  5 in total

1.  Topographical distributions of allelic loss in individual non-small-cell lung cancers.

Authors:  Y Yatabe; H Konishi; T Mitsudomi; S Nakamura; T Takahashi
Journal:  Am J Pathol       Date:  2000-09       Impact factor: 4.307

2.  Clinical significance of p53 mutations in adenocarcinoma of the esophagus and cardia.

Authors:  A P Ireland; D K Shibata; P Chandrasoma; R V Lord; J H Peters; T R DeMeester
Journal:  Ann Surg       Date:  2000-02       Impact factor: 12.969

3.  Inhibitor-sensitive FGFR1 amplification in human non-small cell lung cancer.

Authors:  Amit Dutt; Alex H Ramos; Peter S Hammerman; Craig Mermel; Jeonghee Cho; Tanaz Sharifnia; Ajit Chande; Kumiko Elisa Tanaka; Nicolas Stransky; Heidi Greulich; Nathanael S Gray; Matthew Meyerson
Journal:  PLoS One       Date:  2011-06-07       Impact factor: 3.240

4.  p53 gene aberrations in non-small-cell lung carcinomas from a smoking population.

Authors:  T Liloglou; H Ross; W Prime; R J Donnelly; D A Spandidos; J R Gosney; J K Field
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

5.  Discrimination of double primary lung cancer from intrapulmonary metastasis by p53 gene mutation.

Authors:  D Matsuzoe; T Hideshima; K Ohshima; K Kawahara; T Shirakusa; A Kimura
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.